521 related articles for article (PubMed ID: 32611267)
1. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
[TBL] [Abstract][Full Text] [Related]
2. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
[TBL] [Abstract][Full Text] [Related]
3. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
[TBL] [Abstract][Full Text] [Related]
4. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
[TBL] [Abstract][Full Text] [Related]
5. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
Munroe ME; Lu R; Zhao YD; Fife DA; Robertson JM; Guthridge JM; Niewold TB; Tsokos GC; Keith MP; Harley JB; James JA
Ann Rheum Dis; 2016 Nov; 75(11):2014-2021. PubMed ID: 27088255
[TBL] [Abstract][Full Text] [Related]
6. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
[TBL] [Abstract][Full Text] [Related]
7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
8. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).
Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037
[TBL] [Abstract][Full Text] [Related]
9. Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus.
Eriksson C; Rantapää-Dahlqvist S
Lupus; 2014 Jun; 23(7):691-6. PubMed ID: 24531079
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus.
Torell F; Eketjäll S; Idborg H; Jakobsson PJ; Gunnarsson I; Svenungsson E; Trygg J
J Proteome Res; 2019 Mar; 18(3):1208-1217. PubMed ID: 30742448
[TBL] [Abstract][Full Text] [Related]
12. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
[TBL] [Abstract][Full Text] [Related]
13. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
15. Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b.
Khan WA; Qureshi JA
APMIS; 2015 Dec; 123(12):1016-24. PubMed ID: 26547367
[TBL] [Abstract][Full Text] [Related]
16. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus.
Haddon DJ; Diep VK; Price JV; Limb C; Utz PJ; Balboni I
Arthritis Res Ther; 2015 Jun; 17(1):162. PubMed ID: 26081107
[TBL] [Abstract][Full Text] [Related]
17. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
[TBL] [Abstract][Full Text] [Related]
18. Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.
Morimoto AM; Flesher DT; Yang J; Wolslegel K; Wang X; Brady A; Abbas AR; Quarmby V; Wakshull E; Richardson B; Townsend MJ; Behrens TW
Arthritis Rheum; 2011 Aug; 63(8):2407-15. PubMed ID: 21506093
[TBL] [Abstract][Full Text] [Related]
19. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
